Synthetic triacylated lipopeptides are potent immune adjuvants that mimic the structure of bacterial lipopeptides, key components of microbial cell walls. These synthetic molecules are designed to activate the innate immune system by engaging Toll-like receptor 2 (TLR2), often in cooperation with TLR1. This activation triggers a signaling cascade that leads to the production of pro-inflammatory cytokines, effectively enhancing the adaptive immune response to co-administered antigens.